> top > docs > PMC:7346000 > spans > 30933-31786 > annotations

PMC:7346000 / 30933-31786 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T240 403-406 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T241 618-621 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T242 837-840 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T232 223-226 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T233 302-304 http://www.ebi.ac.uk/efo/EFO_0000265 denotes Da
T234 433-434 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T235 527-529 http://www.ebi.ac.uk/efo/EFO_0000265 denotes Da

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T172 0-853 Sentence denotes O.A.C. is supported by the German Federal Ministry of Research and Education; is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy (CECAD, EXC 2030 - 390661388); has received research grants from Actelion, Amplyx, Astellas, Basilea, Cidara, Da Volterra, F2G, Gilead, Janssen Pharmaceuticals, Medicines Company, MedPace, Melinta Therapeutics, MSD, Pfizer, and Scynexis; is a consultant to Actelion, Allecra Therapeutics, Amplyx, Astellas, Basilea, Biosys UK, Cidara, Da Volterra, Entasis, F2G, Gilead, Matinas, MedPace, Menarini Ricerche, Roche Diagnostics, MSD, Nabriva Therapeutics, Octapharma, Paratek Pharmaceuticals, Pfizer, PSI, Rempex, Scynexis, Seres Therapeutics, Tetraphase, and Vical; and received lecture honoraria from Astellas, Basilea, Gilead, Grupo Biotoscana, MSD, and Pfizer.